| __timestamp | Amphastar Pharmaceuticals, Inc. | Wave Life Sciences Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 2395000 |
| Thursday, January 1, 2015 | 37065000 | 9057000 |
| Friday, January 1, 2016 | 41199000 | 40818000 |
| Sunday, January 1, 2017 | 43415000 | 79309000 |
| Monday, January 1, 2018 | 57564000 | 134428000 |
| Tuesday, January 1, 2019 | 68853000 | 175431000 |
| Wednesday, January 1, 2020 | 67229000 | 130944000 |
| Friday, January 1, 2021 | 60932000 | 121875000 |
| Saturday, January 1, 2022 | 74771000 | 115856000 |
| Sunday, January 1, 2023 | 73741000 | 130009000 |
Data in motion
In the competitive landscape of pharmaceuticals, innovation is key. Over the past decade, Wave Life Sciences Ltd. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting approaches to research and development (R&D) spending. Since 2014, Wave Life Sciences has consistently outpaced Amphastar, with its R&D expenses peaking at approximately 175% higher in 2019. This trend underscores Wave's commitment to pioneering advancements, while Amphastar's more conservative spending reflects a different strategic focus. Notably, Wave's R&D investment surged by over 5,300% from 2014 to 2019, highlighting its aggressive pursuit of innovation. Meanwhile, Amphastar's spending grew by a more modest 160% during the same period. As of 2023, both companies continue to invest heavily in R&D, with Wave maintaining a significant lead. This data offers a fascinating glimpse into how two industry players allocate resources to fuel future growth.
Research and Development Expenses Breakdown: Zoetis Inc. vs Wave Life Sciences Ltd.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Biogen Inc. vs Wave Life Sciences Ltd.
R&D Insights: How Incyte Corporation and Wave Life Sciences Ltd. Allocate Funds
R&D Spending Showdown: Exelixis, Inc. vs Wave Life Sciences Ltd.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Analyzing R&D Budgets: Vericel Corporation vs Wave Life Sciences Ltd.
Research and Development Investment: HUTCHMED (China) Limited vs Wave Life Sciences Ltd.
R&D Spending Showdown: Soleno Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.